182 related articles for article (PubMed ID: 10898417)
1. PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement.
Kastrati A; Koch W; Gawaz M; Mehilli J; Böttiger C; Schömig K; von Beckerath N; Schömig A
J Am Coll Cardiol; 2000 Jul; 36(1):84-9. PubMed ID: 10898417
[TBL] [Abstract][Full Text] [Related]
2. Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease.
Addad F; Elalamy I; Chakroun T; Abderrazek F; Dridi Z; Hamdi S; Hassine M; Ben-Farhat M; Gerotziafas G; Hatmi M; Gamra H
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):674-8. PubMed ID: 20739877
[TBL] [Abstract][Full Text] [Related]
3. PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications.
Goldschmidt-Clermont PJ; Cooke GE; Eaton GM; Binkley PF
J Am Coll Cardiol; 2000 Jul; 36(1):90-3. PubMed ID: 10898418
[No Abstract] [Full Text] [Related]
4. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.
Kastrati A; Schömig A; Seyfarth M; Koch W; Elezi S; Böttiger C; Mehilli J; Schömig K; von Beckerath N
Circulation; 1999 Mar; 99(8):1005-10. PubMed ID: 10051292
[TBL] [Abstract][Full Text] [Related]
5. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis.
Mikkelsson J; Perola M; Penttilä A; Goldschmidt-Clermont PJ; Karhunen PJ
Atherosclerosis; 2001 Feb; 154(3):721-7. PubMed ID: 11257275
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death.
Mikkelsson J; Perola M; Laippala P; Penttilä A; Karhunen PJ
J Am Coll Cardiol; 2000 Oct; 36(4):1317-23. PubMed ID: 11028489
[TBL] [Abstract][Full Text] [Related]
7. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
Newman PJ; Derbes RS; Aster RH
J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
[TBL] [Abstract][Full Text] [Related]
8. No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction.
Lagercrantz J; Bergman M; Lundman P; Tornvall P; Hjemdahl P; Hamsten A; Eriksson P
Blood Coagul Fibrinolysis; 2003 Dec; 14(8):749-53. PubMed ID: 14614355
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly.
Mikkelsson J; Perola M; Laippala P; Savolainen V; Pajarinen J; Lalu K; Penttilä A; Karhunen PJ
Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2573-8. PubMed ID: 10521390
[TBL] [Abstract][Full Text] [Related]
10. Reduced inhibition by abciximab in platelets with the PlA2 polymorphism.
Wheeler GL; Braden GA; Bray PF; Marciniak SJ; Mascelli MA; Sane DC
Am Heart J; 2002 Jan; 143(1):76-82. PubMed ID: 11773915
[TBL] [Abstract][Full Text] [Related]
11. [Polymorphism of GPIIIA platelet glycoprotein gene PIA1/A2 compared to plasma hemostasis in myocardial infarction patients].
Tereshchenko SN; Levchuk NN; Drozdov VN; Shaĭkhaev GO; Leont'ev SG; Kirienko AI; Moiseev VS
Ter Arkh; 1999; 71(9):66-70. PubMed ID: 10553630
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein Ia gene C807T polymorphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting.
von Beckerath N; Koch W; Mehilli J; Böttiger C; Schömig A; Kastrati A
Blood; 2000 Jun; 95(11):3297-301. PubMed ID: 10828008
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
Bennett JS; Catella-Lawson F; Rut AR; Vilaire G; Qi W; Kapoor SC; Murphy S; FitzGerald GA
Blood; 2001 May; 97(10):3093-9. PubMed ID: 11342435
[TBL] [Abstract][Full Text] [Related]
14. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
[TBL] [Abstract][Full Text] [Related]
15. PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Alfonso F; Sabaté M; Fernández C; Stranieri C; Trabetti E; Pignatti PF; Macaya C
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):89-93. PubMed ID: 15166949
[TBL] [Abstract][Full Text] [Related]
16. PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty.
Mamotte CD; van Bockxmeer FM; Taylor RR
Am J Cardiol; 1998 Jul; 82(1):13-6. PubMed ID: 9671001
[TBL] [Abstract][Full Text] [Related]
17. The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with deep venous thrombosis.
Renner W; Winkler M; Hoffmann C; Köppel H; Seinost G; Brodmann M; Pilger E
Int Angiol; 2001 Jun; 20(2):148-51. PubMed ID: 11533523
[TBL] [Abstract][Full Text] [Related]
18. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
19. Association of the platelet glycoprotein receptor IIIa (PlA1/PlA1) genotype with coronary artery disease in Arabs.
Abu-Amero KK; Wyngaard CA; Dzimiri N
Blood Coagul Fibrinolysis; 2004 Jan; 15(1):77-9. PubMed ID: 15166947
[TBL] [Abstract][Full Text] [Related]
20. Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism.
Durante-Mangoni E; Davies GJ; Ahmed N; Ruggiero G; Tuddenham EG
Thromb Haemost; 1998 Aug; 80(2):218-9. PubMed ID: 9716140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
